Tuesday, November 21, 2006

Intradigm Raises $16M For RNA Interference Technology

Palo Alto-based Intradigm has raised $16M in a Series A funding, the firm said today. The round closed over five months ago, in May of this year, and was lead by Alta Partners and Frazier Healthcare Ventures. Other investors included Emerging Technology Partners (ETP), Novartis' Ventures Fund, MediBic Alliance/Daiichi and Genentech. The firm is relocating its new facilities in Palo Alto from Rockville, Maryland. More information »